SCIOSCIA, CRESCENZIO
 Distribuzione geografica
Continente #
NA - Nord America 3.530
EU - Europa 613
AS - Asia 225
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 4.375
Nazione #
US - Stati Uniti d'America 3.525
SE - Svezia 259
CN - Cina 193
FR - Francia 85
DE - Germania 78
IT - Italia 60
GB - Regno Unito 43
BE - Belgio 34
FI - Finlandia 20
UA - Ucraina 16
IR - Iran 10
IN - India 7
IE - Irlanda 6
RU - Federazione Russa 5
AU - Australia 4
TR - Turchia 4
CA - Canada 3
ID - Indonesia 3
AT - Austria 2
JP - Giappone 2
NL - Olanda 2
PA - Panama 2
VN - Vietnam 2
BR - Brasile 1
EU - Europa 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MP - Marianne Settentrionali, isole 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.375
Città #
Fairfield 487
Chandler 449
Woodbridge 326
Seattle 266
Houston 260
Ashburn 258
Ann Arbor 253
Nyköping 227
Cambridge 197
Wilmington 164
Beijing 70
Dearborn 68
Lawrence 62
Roxbury 62
Jacksonville 61
New York 41
Des Moines 39
Inglewood 38
Nanjing 34
Brussels 33
Paris 26
San Diego 26
Bari 21
Boardman 21
Brooklyn 21
Princeton 19
Redwood City 17
Hebei 16
Shenyang 9
London 8
Washington 8
Guangzhou 7
San Mateo 7
Dublin 6
Hefei 6
Jiaxing 6
Jinan 6
Ardabil 5
Changsha 5
Kunming 5
Leawood 5
Nanchang 4
Augusta 3
Grumo Appula 3
Prescot 3
Toronto 3
Dong Ket 2
Hangzhou 2
Istanbul 2
Kilburn 2
Milan 2
Monmouth Junction 2
New Delhi 2
San Francisco 2
Shanghai 2
Shaoxing 2
Stockholm 2
Vienna 2
Adelaide 1
Alba 1
Amsterdam 1
Baotou 1
Belgrade 1
Bratislava 1
Canberra 1
Central 1
Chengdu 1
Chicago 1
Chongqing 1
Edinburgh 1
Esslingen am Neckar 1
Florence 1
Fuzhou 1
Groningen 1
Haikou 1
Hounslow 1
Hyderabad 1
Indiana 1
Jakarta 1
Liedekerke 1
Lignano Sabbiadoro 1
Los Angeles 1
Melbourne 1
Moscow 1
Mumbai 1
Nagold 1
Nanning 1
Oklahoma City 1
Panama City 1
Paracambi 1
Pars 1
Pune 1
Saipan 1
Sydney 1
Taian 1
Taizhou 1
Tappahannock 1
Taranto 1
Tel Aviv 1
Tianjin 1
Totale 3.727
Nome #
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 115
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 107
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 106
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 105
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 103
null 101
null 97
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 96
Old and new antirheumatic drugs and the risk of hepatotoxicity 95
Diffusion and applications of musculoskeletal ultrasound in Italian Rheumatology Units 94
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 91
A knowledge-based framework enabling decision support in RFID solutions for healthcare 88
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 88
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 87
null 84
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 84
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 83
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 83
null 82
null 82
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 81
null 79
AB1114 Three Years Experience with “Sustain”, an Extra-Hospital Infusion Programme for Patients with Rheumatoid Arthritis Treated with Abatacept 78
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 78
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 77
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 75
null 73
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 72
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 72
The italian MSUS study group recommendations for the format and content of the report and documentation in musculoskeletal ultrasonography in rheumatology 68
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 68
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 68
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 67
null 66
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 64
SAT0061 Concurrent Ultrasound-Detected Synovitis and Tenosynovitis Predict Flare in Patients with Rheumatoid Arthritis in Clinical Remission 64
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 64
Response of cartilage oligomeric matrix protein to monoclonal antibody drugs in patients with rheumatoid arthritis 64
OP0217 Ultrasound-Detected Synovitis and Tenosynovitis Independently Associate with Flare in Patients with Rheumatoid Arthritis in Clinical Remission 62
Different joint and skin clinical response of patients with psoriatic arthritis treated with infliximab 58
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 58
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 57
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 55
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 55
Integrin expression on human osteoblasts in osteoarthritis 55
Osteocalcin production by osteoarthritic osteoblasts after vitamin D stimulation 55
Serum cartilage oligomeric matrix protein (COMP) following infliximab treatment in patients with rheumatoid arthritis: Analitical performances and clinical correlations 54
null 53
The treatment of recurrent uveitis with TNF-alpha inhibitors 52
Infliximab therapy in patients with rheumatic disease and HCV chronic infection 49
Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis 47
null 46
Giant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab 46
Increased Bcl-2/p53 ratio in human articular cartilage: a possible role in regulation of chondrocyte metabolism 45
null 45
null 44
Leukocytoclastic vasculitis as onset symptom of ulcerative colitis 41
COMP serum levels in patients with rheumatoid arthritis before and after infliximab therapy 39
Use of etanercept in the treatment of dermatomyositis: a case series 37
Ultrasound-Detected Tenosynovitis Independently Associates with Flare in Patients with Rheumatoid Arthritis in Clinical Remission 37
Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey 32
Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2) 30
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) 29
Economical Evaluation of the Sustain Program for the Out-of-Hospital Administration of Abatacept for Rheumatoid Arthritis 26
Musculoskeletal ultrasonography for psoriatic arthritis and psoriasis patients: A systematic literature review 25
Repeated infusions of low-dose infliximab plus methotrexate in psoriathic arthrtritis: immediate benefitis are not maintained after discontinuation of inlfiximab 23
Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: Results by Italian DELphi in psoriatic arthritis (IDEA) 23
Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis 19
Ultrasonography in psoriatic arthritis: Which sites should we scan? 16
Use of ultrasound in treatment decisions for patients with rheumatoid arthritis: an observational study in Italy 15
Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: Results from the observational study STARTER of the Italian Society for Rheumatology 15
Influence of TNF- α inhibition on oxidative stress of rheumatoid arthritis patients 10
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study 8
L'obésité diminue le maintien thérapeutique des traitements biologiques de seconde ligne après échec d'un anti-TNF de première ligne au cours de la polyarthrite rhumatoïde 7
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 5
Totale 4.522
Categoria #
all - tutte 16.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.959


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019233 0 0 0 0 0 0 0 0 0 45 96 92
2019/20201.387 125 27 26 73 92 245 219 181 191 90 76 42
2020/2021739 39 89 42 49 78 26 91 102 43 79 60 41
2021/2022537 39 41 8 25 26 40 15 23 24 44 79 173
2022/20231.034 114 150 82 116 113 130 29 108 144 10 23 15
2023/2024211 18 57 15 22 19 59 4 13 4 0 0 0
Totale 4.522